TipRanks
Sinopharm Group Co (DE:X2S1)
FRANKFURT:X2S1
Germany Market
X2S1
Sinopharm Group Co
RESEARCH TOOLSreports

Sinopharm Group Co (X2S1) Income Statement

1 Followers

Sinopharm Group Co Income Statement

Last quarter (Q2 2026), Sinopharm Group Co's total revenue was ¥279.68B, a decrease of -5.11% from the same quarter last year. In Q2, Sinopharm Group Co's net income was ¥3.37B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 559.50B¥ 584.51B¥ 596.57B¥ 552.15B¥ 521.05B
Gross Profit
¥ 40.09B¥ 44.26B¥ 48.51B¥ 47.43B¥ 44.05B
Operating Expenses
¥ 23.88B¥ 28.07B¥ 28.30B¥ 26.83B¥ 24.34B
Depreciation and Amortization
¥ 4.29B¥ 4.73B¥ 4.43B¥ 4.17B¥ 3.92B
EBITDA
¥ 20.50B¥ 22.55B¥ 26.90B¥ 26.25B¥ 24.68B
Operating Income
¥ 16.21B¥ 16.19B¥ 20.21B¥ 20.60B¥ 19.71B
Other Income/Expenses
¥ -1.82B¥ -2.19B¥ -697.06M¥ -2.04B¥ -2.71B
Pretax Income
¥ 14.40B¥ 14.00B¥ 19.51B¥ 18.56B¥ 17.00B
Net Income
¥ 6.96B¥ 7.05B¥ 9.05B¥ 8.53B¥ 7.76B
Per Share Metrics
Basic EPS
¥ 11.10¥ 11.30¥ 14.50¥ 13.65¥ 12.45
Diluted EPS
¥ 11.10¥ 11.30¥ 14.50¥ 13.65¥ 12.45
Weighted Average Shares Outstanding
 624.11M 624.11M 624.13M 624.13M 622.23M
Weighted Average Shares Outstanding (Diluted)
 624.11M 624.11M 624.13M 624.13M 622.23M
Currency in CNY

Sinopharm Group Co Earnings and Revenue History